Posted on: September 24, 2019 Posted by: earlenehands Comments: 0

Sandip Patel, MD, describes the ideal patient to receive Alimta + Keytruda based on Keynote-189



Dr. Patel, Assistant Professor of Medicine, Deputy Director, San Diego Center for Precision Immunotherapy, Co-Leader, Experimental Therapeutics (Phase 1), UC San Diego Moores Cancer Center, describes the ideal patient to receive Alimta plus Keytruda based on the initial and updated results of Keynote-189

source: https://medinaportal.net

Xem thêm các bài viết về Sức Khỏe: https://medinaportal.net/category/suc-khoe/

Categories:

Leave a Comment